In this study, it is demonstrated that the NNMT‐specific metabolite, 1‐methyl‐nicotinamide (1‐MNA), promotes breast cancer cell‐cycle progression by enhancing CRL1‐mediated degradation of p27 proteins. Here, NNMT is linked to breast carcinoma.